Publications by authors named "Thomas Dorr"

Claim this Profile
E
Evaluation of Uracil, Sodium Ascorbate, and Rosiglitazone as Promoters of Urinary Bladder Transitional Cell Carcinomas in Male Sprague-Dawley Rats.
Mark Tirmenstein, Evan Janovitz, Thomas Dorr, Yunling Song, Shen-Jue Chen

Toxicol Pathol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of the Zucker Diabetic Fatty (ZDF) Rat Model for Investigating Hypoglycemia-related Toxicities.
Mark Tirmenstein, Joseph Horvath, Michael Graziano, Raja Mangipudy, Thomas Dorr

Toxicol Pathol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical toxicology assessments support the chronic safety of dapagliflozin, a first-in-class sodium-glucose cotransporter 2 inhibitor.
Mark Tirmenstein, Thomas E Dorr, Evan B Janovitz, Deborah Hagan, Lynn M Abell

Int J Toxicol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinogenicity risk assessment supports the chronic safety of dapagliflozin, an inhibitor of sodium-glucose co-transporter 2, in the treatment of type 2 diabetes mellitus.
Timothy P Reilly, Michael J Graziano, Evan B Janovitz, Thomas E Dorr, Craig Fairchild

Diabetes Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis